糠酸氟替卡松 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "糠酸氟替卡松" in Chinese language version.

refsWebsite

Global rank Chinese rank

2web.archive.org

1^st place

1^st place

4,489^th place

2,957^th place

4^th place

5^th place

2^nd place

23^rd place

447^th place

581^st place

doi.org

dx.doi.org

Bruni FM, De Luca G, Venturoli V, Boner AL. Intranasal corticosteroids and adrenal suppression. Neuroimmunomodulation. 2009, 16 (5): 353–62 [2013-10-31]. PMID 19571596. doi:10.1159/000216193. （原始内容存档于2011-11-22）.

fda.gov

FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease. Food and Drug Administration. May 10, 2013 [2013-10-31]. （原始内容存档于2017-01-18）.

karger.com

content.karger.com

Bruni FM, De Luca G, Venturoli V, Boner AL. Intranasal corticosteroids and adrenal suppression. Neuroimmunomodulation. 2009, 16 (5): 353–62 [2013-10-31]. PMID 19571596. doi:10.1159/000216193. （原始内容存档于2011-11-22）.

nih.gov

ncbi.nlm.nih.gov

Bruni FM, De Luca G, Venturoli V, Boner AL. Intranasal corticosteroids and adrenal suppression. Neuroimmunomodulation. 2009, 16 (5): 353–62 [2013-10-31]. PMID 19571596. doi:10.1159/000216193. （原始内容存档于2011-11-22）.

web.archive.org

Bruni FM, De Luca G, Venturoli V, Boner AL. Intranasal corticosteroids and adrenal suppression. Neuroimmunomodulation. 2009, 16 (5): 353–62 [2013-10-31]. PMID 19571596. doi:10.1159/000216193. （原始内容存档于2011-11-22）.
FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease. Food and Drug Administration. May 10, 2013 [2013-10-31]. （原始内容存档于2017-01-18）.